This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Banholzer, R. Articles by Moroni, C. Search for Related Content PubMed PubMed Citation Articles by Banholzer, R. Articles by Moroni, C.

 Previous Article  |  Next Article 

Mol. Cell. Biol., 06 1997, 3254-3260, Vol 17, No. 6
Copyright © 1997, American Society for Microbiology

Rapamycin destabilizes interleukin-3 mRNA in autocrine tumor cells by a mechanism requiring an intact 3' untranslated region

R Banholzer, AP Nair, HH Hirsch, XF Ming and C Moroni
Institute for Medical Microbiology, University of Basel, Switzerland.

We analyzed the effect of rapamycin on autocrine mast cell tumor lines with abnormally stable interleukin-3 (IL-3) transcripts due to a defect in mRNA degradation. Rapamycin inhibited IL-3 mRNA expression specifically, while transcripts of IL-4 and IL-6 were not affected. As indicated by the use of the transcriptional inhibitor actinomycin D or by reporter constructs, inhibition was posttranscriptional and resulted from destabilization of the mRNA. Transcripts from transgenes lacking the AU-rich 3' untranslated region were refractory to drug-induced degradation, suggesting that these 3' sequences contain the target of the rapamycin effect. Rapamycin did not promote IL-3 mRNA degradation in cells of a tumor variant lacking expression of FKBP12, the binding protein of rapamycin. Experiments with wortmannin indicated that rapamycin does not act via p70S6 kinase. FK-506, another ligand of FKBP12 affecting the phosphatase calcineurin, did not antagonize but shared the effect of rapamycin. Our data fit a model whereby both FKBP12 and calcineurin target an unknown regulator of IL-3 mRNA turnover.

This article has been cited by other articles:

• Ren, J., Mi, Z., Stewart, N. A., Jackson, E. K. (2009). Identification and Quantification of 2',3'-cAMP Release by the Kidney. J. Pharmacol. Exp. Ther. 328: 855-865 [Abstract] [Full Text]  
• Inoki, K., Ouyang, H., Li, Y., Guan, K.-L. (2005). Signaling by Target of Rapamycin Proteins in Cell Growth Control. Microbiol. Mol. Biol. Rev. 69: 79-100 [Abstract] [Full Text]  
• Benjamin, D., Colombi, M., Moroni, C. (2004). A GFP-based assay for rapid screening of compounds affecting ARE-dependent mRNA turnover. Nucleic Acids Res 32: e89-e89 [Abstract] [Full Text]  
• Shegogue, D., Trojanowska, M. (2004). Mammalian Target of Rapamycin Positively Regulates Collagen Type I Production via a Phosphatidylinositol 3-Kinase-independent Pathway. J. Biol. Chem. 279: 23166-23175 [Abstract] [Full Text]  
• Cook, H. L., Mischo, H. E., Steitz, J. A. (2004). The Herpesvirus saimiri Small Nuclear RNAs Recruit AU-Rich Element-Binding Proteins but Do Not Alter Host AU-Rich Element-Containing mRNA Levels in Virally Transformed T Cells. Mol. Cell. Biol. 24: 4522-4533 [Abstract] [Full Text]  
• Crespo, J. L., Hall, M. N. (2002). Elucidating TOR Signaling and Rapamycin Action: Lessons from Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev. 66: 579-591 [Abstract] [Full Text]  
• Albig, A. R., Decker, C. J. (2001). The Target of Rapamycin Signaling Pathway Regulates mRNA Turnover in the Yeast Saccharomyces cerevisiae. Mol. Biol. Cell 12: 3428-3438 [Abstract] [Full Text]  
• Ming, X.-F., Stoecklin, G., Lu, M., Looser, R., Moroni, C. (2001). Parallel and Independent Regulation of Interleukin-3 mRNA Turnover by Phosphatidylinositol 3-Kinase and p38 Mitogen-Activated Protein Kinase. Mol. Cell. Biol. 21: 5778-5789 [Abstract] [Full Text]  
• Montero, L., Nagamine, Y. (1999). Regulation by p38 Mitogen-activated Protein Kinase of Adenylate- and Uridylate-Rich Element-mediated Urokinase-Type Plasminogen Activator (uPA) Messenger RNA Stability and uPA-dependent in Vitro Cell Invasion. Cancer Res. 59: 5286-5293 [Abstract] [Full Text]  
• Nair, A. P. K., Hirsch, H. H., Colombi, M., Moroni, C. (1999). Cyclosporin A Promotes Translational Silencing of Autocrine Interleukin-3 via Ribosome-Associated Deadenylation. Mol. Cell. Biol. 19: 889-898 [Abstract] [Full Text]  
• Hashemolhosseini, S., Nagamine, Y., Morley, S. J., Desrivieres, S., Mercep, L., Ferrari, S. (1998). Rapamycin Inhibition of the G1 to S Transition Is Mediated by Effects on Cyclin D1 mRNA and Protein Stability. J. Biol. Chem. 273: 14424-14429 [Abstract] [Full Text]